QA: Wave Life Sciences Ltd. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001631574_2023_Wave_Life_Sciences_Ltd.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'First Wave BioPharma Inc.', 'shared_tokens': {'wave'}}]}

Graph

Absolute values for 0001631574, Wave Life Sciences Ltd.

  xvar xval
0 AssetsCurrent 98,537,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 17,284,000
3 remainder_Assets 30,565,000
4 LiabilitiesCurrent 71,521,000
5 LiabilitiesNoncurrent 112,082,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 50,513,000
9 ResearchAndDevelopmentExpense 115,856,000
10 remainder_Expenses 681,000
11 remainder_Revenues 3,649,000
12 remainder_NetIncome 1,578,000
13 remainder_ComprehensiveNetIncome -210,000
  yvar yval
0 Assets 146,386,000
1 Liabilities 183,603,000
2 Expenses 167,050,000
3 Revenues 3,649,000
4 StockholdersEquity -37,217,000
5 NetIncome -161,823,000
6 ComprehensiveNetIncome -161,928,000
7 BaseVar 251,238,000
8 EconomicCapitalRatio -1.37

Edgar->Model Mapping

Feature Distribution

Change over Time